What is an E-Signature and What Does It Mean in the Medical Device Industry
As companies move toward digital transformation in the medical device industry, there are many aspects to consider when transitioning from paper systems to digital systems. One key component is the electronic signature (e-signature).
Electronic signatures, as defined by the FDA, are electronic identifications of intent to sign a record, which are legally binding and equivalent to handwritten signatures.
Therefore, in the medical device industry, e-signatures are primarily regulated through 21 Code of Federal Regulations (CFR) Part 11, which sets criteria for electronic systems to be considered trustworthy, reliable, and equivalent to paper records. More specifically, e-signature requirements are defined under 21 CFR Part 11 Subpart C.
For the sake of this article, let’s consider a mid-sized medical device manufacturer that transitioned from paper-based batch records to a digital system. By implementing e-signatures:
- Operators could sign off on completed tasks electronically.
- QA personnel could review and approve records without printing documents.
- The audit trail allowed the company to quickly demonstrate compliance during an FDA inspection.
This process reduced the approval cycle from days to hours while maintaining the legality and security of signatures.
Understanding 21 CFR Part 11 and E-Signature Requirements
In the medical device industry, electronic signatures (e-signatures) are an essential part of digital records management. The FDA regulates e-signatures through 21 CFR Part 11, which ensures that electronic records are trustworthy, reliable, and legally equivalent to traditional paper records.
Let’s break this down into 4 key parts to understand the key e-signature requirements and how they are implemented in practice.
1. General Requirements
Each e-signature must be unique to an individual. E-signatures must never be reused or reassigned, and they can only be issued after the person’s identity is properly verified. Organizations are also required to confirm to the FDA that their e-signatures are legally equivalent to handwritten signatures, ensuring compliance and maintaining legal validity.
2. Electronic Signature Components and Controls
For e-signatures that are not based on biometrics, the system must use at least two distinct identifiers, such as a username and password. These signatures must be used only by their genuine owners, with safeguards in place to prevent misuse or unauthorized reuse. Additionally, if a signature is applied multiple times during a session, it must be authenticated at the start and again after a defined period of inactivity as specified by the system.
For biometric signatures, systems must ensure that they cannot be used by anyone other than the genuine owner, protecting the integrity and authenticity of each signature.
3. Controls for Identification Codes and Passwords
Organizations must maintain the uniqueness and security of identification codes and passwords used as part of e-signature authentication. Security measures may include periodic password revisions, safeguards against unauthorized use, loss, or theft, and procedures to deauthorize compromised credentials. These controls also apply to tokens, cards, or other devices used to generate identification codes or password information, ensuring secure and reliable access.
4. Implementing E-Signatures in Practice
Many software solutions in the medical device industry are designed to comply with 21 CFR Part 11, allowing organizations to implement secure e-signatures within their workflows.
In compliant systems (such as purpose-built solutions for regulated industries), e-signatures include three key components: the meaning of the signature, the username, and the password. Organizations can customize where e-signatures are required, define user permissions, and even require multiple signatures for certain tasks. For example, a checklist might first be signed by the operator who completed the work, and then reviewed and signed by a QA professional for verification.
E-signatures can also support paperless approvals for critical processes such as design revisions or batch records, significantly reducing delays in approval cycles. Systems often maintain complete audit trails, showing who performed each action, when, and why, information that is essential for FDA inspections and internal quality audits.
Overall, e-signatures are a critical part of digital transformation in the medical device industry. Proper implementation in compliance with 21 CFR Part 11 ensures that electronic records are legally binding, secure, and auditable, matching or even exceeding the integrity of traditional paper records.